Literature DB >> 8431017

Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans.

G Samonis1, A Gikas, E J Anaissie, G Vrenzos, S Maraki, Y Tselentis, G P Bodey.   

Abstract

This study evaluated the effects of broad-spectrum antibiotics on the gastrointestinal (G.I.) yeast flora of humans and correlated the findings with those obtained from a mouse model of G.I. colonization by Candida albicans. We prospectively studied 46 adult cancer patients who received one of five broad-spectrum antibiotics (ceftriaxone, ceftazidime, ticarcillin-clavulanic acid, imipenem-cilastatin, and aztreonam) as therapy for infections. Quantitative examination of yeast colonization of stools was conducted at the baseline, at the end of antibiotic treatment, and 1 week after discontinuation of therapy. Antibiotics with anaerobic activity (ticarcillin-clavulanic acid) or high G.I. concentrations (ceftriaxone) caused a higher and more sustained increase in G.I. colonization by yeasts than did antibiotics with poor anaerobic activity (ceftazidime and aztreonam) or a low G.I. concentration (imipenem-cilastatin). These results were similar to those obtained with a mouse model of G.I. colonization by C. albicans that involved the same antibiotics. Hence, the mouse model may be useful for evaluation of yeast colonization of the human G.I. tract.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431017      PMCID: PMC187603          DOI: 10.1128/AAC.37.1.51

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology.

Authors:  R L Myerowitz; G J Pazin; C M Allen
Journal:  Am J Clin Pathol       Date:  1977-07       Impact factor: 2.493

2.  Prophylaxis of candidiasis in cancer patients.

Authors:  G P Bodey; G Samonis; K Rolston
Journal:  Semin Oncol       Date:  1990-06       Impact factor: 4.929

3.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

Authors:  E J Freireich; E A Gehan; D P Rall; L H Schmidt; H E Skipper
Journal:  Cancer Chemother Rep       Date:  1966-05

4.  The rationale for preventing antibacterial-induced fungal overgrowth.

Authors:  M S Seelig
Journal:  Med Times       Date:  1968-07

5.  Candida sepsis: pathogenesis and principles of treatments.

Authors:  H H Stone; L D Kolb; C A Currie; C E Geheber; J Z Cuzzell
Journal:  Ann Surg       Date:  1974-05       Impact factor: 12.969

6.  Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice.

Authors:  G Samonis; E J Anaissie; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

7.  Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.

Authors:  S R Norrby; K Alestig; F Ferber; J L Huber; K H Jones; F M Kahan; M A Meisinger; J D Rogers
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

8.  Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

Authors:  H C Neu; N J Meropol; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

9.  Selective decontamination of the digestive tract with aztreonam: a study of 10 healthy volunteers.

Authors:  H G de Vries-Hospers; G W Welling; E A Swabb; D van der Waaij
Journal:  J Infect Dis       Date:  1984-11       Impact factor: 5.226

10.  Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

View more
  52 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Chicken Intestinal Mycobiome: Initial Characterization and Its Response to Bacitracin Methylene Disalicylate.

Authors:  Kelsy Robinson; Yingping Xiao; Timothy J Johnson; Binlong Chen; Qing Yang; Wentao Lyu; Jing Wang; Nicole Fansler; Sage Becker; Jing Liu; Hua Yang; Guolong Zhang
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

3.  The Role of the Intestinal Tract As a Source for Transmission of Nosocomial Pathogens.

Authors:  Usha Stiefel; Curtis J Donskey
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

4.  Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice.

Authors:  Nicole J Pultz; Usha Stiefel; Mahmoud Ghannoum; Marion S Helfand; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 5.  Murine models of Candida gastrointestinal colonization and dissemination.

Authors:  Andrew Y Koh
Journal:  Eukaryot Cell       Date:  2013-09-13

Review 6.  The mycobiota: interactions between commensal fungi and the host immune system.

Authors:  David M Underhill; Iliyan D Iliev
Journal:  Nat Rev Immunol       Date:  2014-06       Impact factor: 53.106

Review 7.  Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients.

Authors:  Ercole Concia; Anna Maria Azzini; Michela Conti
Journal:  Drugs       Date:  2009       Impact factor: 9.546

8.  Urinary D-arabinitol/L-arabinitol levels in infants undergoing long-term antibiotic therapy.

Authors:  Teresa J Stradomska; Bogumila Bobula-Milewska; Anna Bauer; Zbigniew Mielniczuk; Maria Dabkowska; Malgorzata Syczewska; Danuta Dzierzanowska
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

9.  Gastrointestinal colonization by methicillin-resistant Staphylococcus aureus in immunosuppressed mice.

Authors:  N Kato-Matsunaga; K Okonogi
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

Review 10.  Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care.

Authors:  J L Vincent; E Anaissie; H Bruining; W Demajo; M el-Ebiary; J Haber; Y Hiramatsu; G Nitenberg; P O Nyström; D Pittet; T Rogers; P Sandven; G Sganga; M D Schaller; J Solomkin
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.